Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma

Clinical Cancer Research

Volumn 14, Issue 14, 2008, Pages 4417-4426

  Niikawa, Hiromichi ^a,b,d   Suzuki, Takashi ^b   Miki, Yasuhiro ^a   Suzuki, Satoshi ^c   Nagasaki, Shuji ^a   Akahira, Junichi ^a   Honma, Seijiro ^b   Evans, Dean B ^e   Hayashi, Shin Ichi ^c   Kondo, Takashi ^b   Sasano, Hironobu ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c JAPANESE RED CROSS SOCIETY   (Japan)

^d Teizo Medical Co Ltd   (Japan)

^e NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

1,3,5 TRIS(4 HYDROXYPHENYL) 4 PROPYLPYRAZOLE; AROMATASE; DIARYLPROPIONITRILE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; KI 67 ANTIGEN; LETROZOLE; PROPIONITRILE; PROTEIN 17BETAHSD1; PROTEIN 17BETAHSD2; RALOXIFENE; TAMOXIFEN; TESTOSTERONE; TESTOSTERONE 17BETA DEHYDROGENASE; UNCLASSIFIED DRUG; ESTROGEN; ESTROGEN RECEPTOR; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ADULT; AGED; ARTICLE; CANCER CELL; CELL PROLIFERATION; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIQUID CHROMATOGRAPHY; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX DIFFERENCE; TANDEM MASS SPECTROMETRY; TUMOR VOLUME; CHEMISTRY; DRUG EFFECT; LUNG TUMOR; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AROMATASE; CARCINOMA, NON-SMALL-CELL LUNG; CELL PROLIFERATION; CHROMATOGRAPHY, LIQUID; ESTROGEN RECEPTOR MODULATORS; ESTROGENS; HUMANS; KI-67 ANTIGEN; LUNG NEOPLASMS; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

EID: 51649084814     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-07-1950     Document Type: Article

References (35)

1. Sekine I, Nishiwaki Y, Yokose T, Nagai K, Suzuki K, Kodama T. Young lung cancer patients in Japan: different characteristics between the sexes. Ann Thorac Surg 1999;67:1451-5.
2. Greenlee RT, Murray T, Bolden S. Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000;50:7-33.
3. Jemal A, Chu KC, Tarone RE. Recent trends in lung cancer mortality in the United States. J Natl Cancer Inst 2001;93:277-83.
4. Rom WN, Hay JG, Lee TC, Jiang YTchou-Wong KM. Molecular and genetic aspects of lung cancer. Am J Respir Crit Care Med 2000;161:1355-67.
5. Omoto Y, Kobayashi Y, Nishida K, et al. Expression, function, and clinical implications of the estrogen receptor β in human lung cancers. Biochem Biophys Res Commun 2001;285:340-7.
6. Stabile LP, Davis AL, Gubish CT, et al. Human nonsmall cell lung tumors and cells derived from normal lung express both estrogen receptor α and β and show biological responses to estrogen. Cancer Res 2002;62:2141-50.
7. Mollerup S, Jorgensen K, Berge G, Haugen A. Expression of estrogen receptors a and β in human lung tissue and cell lines. Lung Cancer 2002;37: 153-9.
8. Pietras RJ, Márquez DC, Chen HW, Tsai E, Weinberg O, Fishbein M. Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells. Steroids 2005:70:372-81. Epub 2005 Mar 25.
9. Ganti AK, Sahmoun AE, Panwalkar AW, Tendulkar KK, Potti A. Hormone replacement therapy is associated with decreased survival in women with lung cancer. J Clin Oncol 2006;24:59-63. Epub 2005 Nov 28.
10. Suzuki T, Miki Y, Moriya T, et al. 5α-Reductase type 1 and aromatase in breast carcinoma as regulators of in situ androgen production. Int J Cancer 2007;120: 285-91.
11. Miki Y, Suzuki T, Tazawa C, et al. Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells. Cancer Res 2007;67:3945-54.
12. Suzuki T, Inoue A, Miki Y, et al. Early growth responsive gene 3 (EGR3) in human breast carcinoma: a regulator of estrogen-meditated invasion and a potent prognostic factor. Endocr Relat Cancer 2007;14: 279-92.
13. Suzuki T, Moriya T, Ariga N, Kaneko C, Kanazawa M, Sasano H. 17β-Hydroxysteroid dehydrogenase type 1 and type 2 in human breast carcinoma: a correlation to clinicopathological parameters. Br J Cancer 2000;82: 518-23.
14. Ishibashi H, Suzuki T Suzuki S, et al. Progesterone receptor in non-small cell lung cancer-a potent prognostic factor and possible target for endocrine therapy. Cancer Res 2005;65:6450-8.
15. Suzuki T, Miki Y, Moriya T, et al. 5α-Reductasetype1 and aromatase in breast carcinoma as regulators of in situ androgen production. Int J Cancer 2007;120:285-91.
16. Suzuki T, Takahashi K, Darnel AD, et al. COUP-TFII in the human adrenal cortex and its disorders. J Clin Endocrinol Metab 2000;85:2752-7.
17. Gottfried-Blackmore A, Croft G, McEwen BS, Bulloch K. Transcriptional activity of estrogen receptors ERα and ERβ in the E(t)C1 cerebellar granule cell line. Brain Res 2007;1186:41-7. Epub 2007 Oct 23.
18. Omoto Y, Eguchi H, Yamamoto-Yamaguchi Y, Hayashi S. Estrogen receptor β1 and ERβcx/β2 inhibit ERα function differently in breast cancer cell line MCF7. Oncogene 2003;22:5011-20.
19. Sakamoto T, Eguchi H, Omoto Y, Ayabe T, Mori H, Hayashi S. Estrogen receptor-mediated effects of tamoxifen on human endometrial cancer cells. Mol Cell Endocrinol 2002;192:93-104.
20. Weinberg OK, Marquez-Garban DC, Fishbein MC, et al. Aromatase inhibitors in human lung cancer therapy. Cancer Res 2005;65:11287-91.
21. Chetrite GS, Cortes-Prieto J, Philippe JC, Wright F, Pasqualini JR. Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues. J Steroid Biochem Mol Biol 2000;72:23-7.
22. Suzuki T, Miki Y, Nakamura Y, et al. Sex steroidproducing enzymes in human breast cancer. Endocr Relat Cancer 2005;12:701-20.
23. Provost PR, Blomquist CH, Godin C, et al. Androgen formation and metabolism in the pulmonary epithelial cell line A549: expression of 17β-hydroxysteroid dehydrogenase type 5 and 3α-hydroxysteroid dehydrogenase type 3. Endocrinology 2000;141:2786-94.
24. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S, Gustaf sson JA. Cloning of a novel receptor expressed in rat prostate and ovary Proc Natl Acad Sci U S A 1996;93:5925-30.
25. Enmark E, Pelto-Huikko M, Grandien K, et al. Human estrogen receptor β-gene structure, chromosomal localization, and expression pattern J Clin Endocrinol Metab 1997;82:4258-65.
26. Korach KS. Insights from the study of animals lacking functional estrogen receptor. Science 1994;266: 1524-7.
27. Kawai H, Ishii A, Washiya K, et al. Estrogen receptor α and β are prognostic factors in non-small cell lung cancer. Clin Cancer Res 2005;11:5084-9.
28. Wu CT, Chang YL, Shih JY, Lee YC. The significance of estrogen receptor β in 301 surgically treated nonsmall cell lung cancers J Thorac Cardiovasc Surg 2005;130:979-86.
29. Dabbs DJ, Landreneau RJ, Liu Y, et al. Detection of estrogen receptor by immunohistochemistry in pulmonary adenocarcinoma. Ann Thorac Surg 2002;73: 403-5; discussion 406.
30. Schwartz AG, Prysak GM, Murphy V, et al. Nuclear estrogen receptor β in lung cancer: expression and survival differences by sex. Clin Cancer Res 2005;11:7280-7.
31. Lau SK, Chu PG, Weiss LM. Immunohistochemical expression of estrogen receptor in pulmonary adenocarcinoma. Appl Immunohistochem Mol Morphol 2006;14:83-7
32. Hershberger PA, Vasquez AC, Kanterewicz B, Land S, Siegfried JM, Nichols M. Regulation of endogenous gene expression in human non-small cell lung cancer cells by estrogen receptor ligands. Cancer Res 2005; 65:1598-605.
33. Gerdes J, Schwab U. Lemke H, Stein H Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983;31:13-20.
34. Vendrell JA, Bieche I, Desmetz C, et al Molecular changes associated with the agonist activity of hydroxy-tamoxifen and the hyper-response to estradiol in hydroxy-tamoxifen-resistant breast cancer cell lines. Endocr Relat Cancer 2005;12:75-92
35. Mah V, Seligson DB, Li A, et al. Aromatase expression predicts survival in women with early-stage non small cell lung cancer. Cancer Res 2007;67:10484-90